| |
| |
|
| Insider
Information: |
Luo Mary Z. |
| Relationship: |
COO,Chief Scientist & ... |
| City: |
Rancho Cucamonga |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
2,433,554 |
|
|
Indirect Shares
|
8,057,435 |
|
|
| Direct
Value |
$102,574,301 |
|
|
|
Indirect Value
|
$339,620,885 |
|
|
| Total
Shares |
10,490,989 |
|
|
| Total
Value |
$442,195,186 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amphastar Pharmaceuticals, Inc. |
AMPH |
COO,Chief Scientist & ... |
2024-03-17 |
2,433,554 |
2024-03-17 |
8,057,435 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
170 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
• • • |
2015-06-10 |
4 |
OE |
$12.97 |
$163,668 |
I/I |
12,619 |
674,285 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
• • • |
2015-06-11 |
4/A |
OE |
$12.97 |
$166,794 |
D/D |
12,860 |
936,241 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
• • • |
2015-06-11 |
4 |
OE |
$12.97 |
$166,794 |
D/D |
12,860 |
924,496 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
• • • |
2015-06-11 |
4/A |
OE |
$12.97 |
$167,702 |
I/I |
12,930 |
687,662 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
• • • |
2015-06-11 |
4 |
OE |
$12.97 |
$167,702 |
I/I |
12,930 |
674,596 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
• • • |
2015-06-10 |
4 |
OE |
$12.97 |
$168,286 |
D/D |
12,975 |
924,611 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
• • • |
2015-06-10 |
4/A |
OE |
$12.97 |
$168,286 |
D/D |
12,975 |
935,112 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO Chief Scientist & Chairman |
• • • |
2019-03-17 |
4 |
D |
$20.23 |
$282,026 |
I/I |
(13,941) |
1,399,022 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
CEO & Chief Scientific Officer |
• • • |
2022-03-15 |
4 |
D |
$34.74 |
$512,728 |
D/D |
(14,759) |
2,383,023 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
• • • |
2018-05-16 |
4 |
B |
$16.06 |
$240,854 |
D/D |
15,000 |
2,080,619 |
3.23 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO & Chief Scientist |
• • • |
2015-12-07 |
4 |
AS |
$14.59 |
$219,490 |
I/I |
(15,046) |
7,549,253 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO & Chief Scientist |
• • • |
2015-12-11 |
4 |
AS |
$14.05 |
$211,736 |
I/I |
(15,066) |
7,461,594 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
• • • |
2016-03-26 |
4 |
D |
$11.96 |
$187,904 |
D/D |
(15,711) |
1,114,191 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
CEO & Chief Scientific Officer |
• • • |
2022-03-17 |
4 |
D |
$34.18 |
$538,950 |
D/D |
(15,768) |
2,342,014 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
• • • |
2023-03-17 |
4 |
D |
$36.29 |
$572,221 |
D/D |
(15,768) |
2,078,718 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO,Chief Scientist & Chairman |
• • • |
2024-03-17 |
4 |
D |
$43.05 |
$678,812 |
D/D |
(15,768) |
2,433,554 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
CEO & Chief Science Officer |
– – • |
2015-12-03 |
4 |
AS |
$15.42 |
$286,461 |
I/I |
(18,583) |
7,593,011 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
• • • |
2018-03-16 |
4 |
D |
$19.91 |
$385,458 |
D/D |
(19,360) |
2,091,834 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
CEO & Chief Science Officer |
– – • |
2015-12-01 |
4 |
AS |
$15.49 |
$309,780 |
I/I |
(20,000) |
7,611,594 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO Chief Scientist & Chairman |
• • • |
2018-03-26 |
4 |
D |
$18.61 |
$385,748 |
D/D |
(20,728) |
2,040,619 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
• • • |
2015-03-27 |
4 |
D |
$15.43 |
$322,132 |
D/D |
(20,877) |
911,636 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist Chairman |
• • • |
2017-03-26 |
4 |
D |
$13.76 |
$299,954 |
D/D |
(21,799) |
1,199,982 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO & Chief Scientist |
• • • |
2015-12-10 |
4 |
AS |
$14.32 |
$313,884 |
I/I |
(21,915) |
7,476,660 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO, Chief Scientist, Chairman |
• • • |
2017-03-17 |
4 |
D |
$13.75 |
$317,735 |
D/D |
(23,108) |
1,221,781 |
0 |
- |
|
| AMPH |
Amphastar Pharmaceuticals... |
COO & Chief Scientist |
• • • |
2015-12-08 |
4 |
AS |
$14.50 |
$353,118 |
I/I |
(24,359) |
7,524,894 |
0 |
- |
|
170 Records found
|
|
Page 3 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
